The Effects of Long-term CPAP on Weight Change in Patients With Comorbid OSA and Cardiovascular Disease: Data From the SAVE Trial

Qiong Ou, Baixin Chen, Kelly A. Loffler, Yuanming Luo, Xilong Zhang, Rui Chen, Qian Wang, Luciano F. Drager, Geraldo Lorenzi-Filho, Michael Hlavac, Nigel McArdle, Sutapa Mukherjee, Olga Mediano, Ferran Barbe, Craig S. Anderson, R. Doug McEvoy, Richard J. Woodman, SAVE investigators

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Although recent evidence suggests that OSA treatment may cause weight gain, the long-term effects of CPAP on weight are not well established.

Methods: This study was a post hoc analysis of the Sleep Apnea Cardiovascular Endpoints (SAVE) study, a multicenter, randomized trial of CPAP plus standard care vs standard care alone in adults with a history of cardiac or cerebrovascular events and moderate to severe OSA. Participants with weight, BMI, and neck and waist circumferences measured at baseline and during follow-up were included. Linear mixed models were used to examine sex-specific temporal differences, and a sensitivity analysis compared high CPAP adherers (≥ 4 h per night) with propensity-matched control participants.

Results: A total of 2,483 adults (1,248 in the CPAP group and 1,235 in the control group) were included (mean 6.1 ± 1.5 measures of weight available). After a mean follow-up of 3.78 years, there was no difference in weight change between the CPAP and control groups, for male subjects (mean [95% CI] between-group difference, 0.07 kg [–0.40 to 0.54]; P =.773) or female subjects (mean [95% CI] between-group difference, –0.14 kg [–0.37 to 0.09]; P =.233). Similarly, there were no significant differences in BMI or other anthropometric measures. Although male participants who used CPAP ≥ 4 h per night gained slightly more weight than matched male control subjects without CPAP (mean difference, 0.38 kg [95% CI, 0.04 to 0.73]; P =.031), there were no between-group differences in other anthropometric variables, nor were there any differences between female high CPAP adherers and matched control subjects.

Conclusions: Long-term CPAP use in patients with comorbid OSA and cardiovascular disease does not result in clinically significant weight change. Trial Registry: ClinicalTrials.gov; No.: NCT00738179; URL: www.clinicaltrials.gov.

Original languageEnglish
Pages (from-to)720-729
Number of pages10
JournalChest
Volume155
Issue number4
DOIs
Publication statusPublished - 1 Apr 2019

Keywords

  • CPAP
  • long-term
  • OSA
  • weight

Fingerprint Dive into the research topics of 'The Effects of Long-term CPAP on Weight Change in Patients With Comorbid OSA and Cardiovascular Disease: Data From the SAVE Trial'. Together they form a unique fingerprint.

  • Cite this

    Ou, Q., Chen, B., Loffler, K. A., Luo, Y., Zhang, X., Chen, R., Wang, Q., Drager, L. F., Lorenzi-Filho, G., Hlavac, M., McArdle, N., Mukherjee, S., Mediano, O., Barbe, F., Anderson, C. S., McEvoy, R. D., Woodman, R. J., & SAVE investigators (2019). The Effects of Long-term CPAP on Weight Change in Patients With Comorbid OSA and Cardiovascular Disease: Data From the SAVE Trial. Chest, 155(4), 720-729. https://doi.org/10.1016/j.chest.2018.08.1082